Sutro Biopharma Inc.
04/01/2026 | Press release | Distributed by Public on 04/02/2026 04:07
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 1, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
|
|||||||
Sutro Biopharma Inc. published this content on April 01, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 02, 2026 at 10:09 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]